Research to change how breast cancer treated

September 23, 2013
Simple IMRT. Credit: Charlotte Coles

(Medical Xpress)—Research from the newly formed Cambridge Cancer Centre, a collaboration between the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Cancer Research UK and others, could change how women with breast cancer are treated.

The study, by researchers from Addenbrooke's Hospital and the University of Cambridge led by Dr Charlotte Coles, found that who received treatment with Intensity Modulated Radiation Therapy (IMRT) showed better overall cosmetic results compared to those given standard radiotherapy using only 2-dimensional (2D) planning. The study, which has been funded by the charity Breast Cancer Campaign and the NIHR Cambridge Biomedical Research Centre, was published in the Journal of Clinical Oncology.

For the study, the researchers analysed the radiotherapy treatment plans of 1145 patients with early who had previously had breast-conserving surgery. Of these, 815 women (71%) were identified as potentially being able to benefit from IMRT, and were randomised to receive IMRT or standard radiotherapy. After five years from completion of radiotherapy, 654 women were followed up, 228 having received IMRT.

This study was specifically designed to look at possible improvement in the cosmetic result with IMRT. As expected, there was no difference in survival rates or chance of recurrence between the two treatments. Taking all cosmetic aspects into consideration, the overall cosmetic benefit was greater with IMRT, thanks to less damage to the : 88% (197) of women had good or moderate cosmetic appearance after five years compared to 78% (179) who received the standard 2D radiotherapy. As well as halving the risk of poor cosmesis compared to standard 2D radiotherapy, IMRT also reduced the risk of developing marked skin telangiectasia, (dilated blood vessels appearing near the surface of the skin): 15% (35) compared to 24% (56) who received standard 2D radiotherapy.

Dr Charlotte Coles, a researcher at Addenbrooke's Hospital and Senior Faculty member of the Cambridge Cancer Centre, said: "We strongly believe that quality of life is important, as well as saving lives, and cosmetic results from radiotherapy have a real impact once treatment is finished. It's not trivial or a question of vanity. Poor cosmetic results can affect psychological wellbeing as well leaving a physical scar. It's a visible reminder to the woman that she has had cancer."

Radiotherapy aims to treat the whole breast with an even dose of radiation - too low a dose can lead to cancer coming back, and too high a dose can cause extensive damage to the skin and tissue, leading to visible side-effects that can also be painful. Unlike 2D breast radiotherapy, IMRT accounts for the shape of the breast in three dimensions so that the dose remains even across the breast.

In addition, IMRT has been shown to significantly reduce short term side effects (less weeping and peeling skin), compared to standard 2D breast radiotherapy.

All UK radiotherapy centres have the equipment to provide 3D radiotherapy and simple breast IMRT where appropriate. However, delivery of IMRT has been inconsistent. According to a recent audit one in five radiotherapy centres in the UK are not routinely using simple IMRT.

Baroness Delyth Morgan, Chief Executive of Breast Cancer Campaign said: "These practice changing results give out a clear message that where appropriate women must be given access to IMRT to get the best possible medical and cosmetic results from treatment. We know the technology is in place to deliver IMRT so let's not give women standard treatment if there is something better; women deserve more."

Professor Neil Burnet, Professor of Radiation Oncology at the University of Cambridge, said: "This is a landmark study, with major significance for women with breast cancer. It demonstrates the value to patients, and indeed society, of using modern technology."

Explore further: Intensity modulated radiotherapy reduces side effects in patients with early breast cancer

Related Stories

Intensity modulated radiotherapy reduces side effects in patients with early breast cancer

April 21, 2013
Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European ...

Breast conserving treatment with radiotherapy reduces risk of local recurrence

September 18, 2013
Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ (DCIS). ...

Studies confirm shorter radiotherapy course best option for women with breast cancer

September 18, 2013
The long-term results of the landmark START trials conclusively confirm that giving radiotherapy as a lower overall dose in fewer, higher doses over a shorter treatment time (hypofractionated) is at least as effective and ...

Despite hype, costly prostate cancer treatment offers little relief from side effects

December 13, 2012
Prostate cancer patients receiving the costly treatment known as proton radiotherapy experienced minimal relief from side effects such as incontinence and erectile dysfunction, compared to patients undergoing a standard radiation ...

IMRT reduces risk of side effects in breast cancer patients

March 28, 2012
Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical ...

PRT versus IMRT toxicity in Medicare beneficiaries with prostate cancer

December 17, 2012
There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among Medicare beneficiary patients with prostate cancer at 12 months post-treatment according ...

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.